<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6</volume><submitter>Miyamoto Y</submitter><pubmed_abstract>The data is related to the research article entitled "Hypomyelinating leukodystrophy-associated missense mutation in HSPD1 blunts mitochondrial dynamics" [1]. In addition to hypomyelinating leukodystrophy (HLD) 4 (OMIM no. 612233), it is known that spastic paraplegia (SPG) 13 (OMIM no. 605280) is caused by HSPD1's amino acid mutation. Two amino acid mutations Val-98-to-Ile (V98I) and Gln-461-to-Glu (Q461E) are associated with SPG13 [2]. In order to investigate the effects of HSPD1's V98I or Q461E mutant on mitochondrial morphological changes, we transfected each of the respective mutant-encoding genes into Cos-7 cells. Either of V98I or Q461E mutant exhibited increased number of mitochondria and short length mitochondrial morphologies. Using MitoTracker dye-incorporating assay, decreased mitochondrial membrane potential was also observed in both cases. The data described here supports that SPG13-associated HSPD1 mutant participates in causing aberrant mitochondrial morphological changes with decreased activities.</pubmed_abstract><journal>Data in brief</journal><pagination>482-8</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4716458</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Data supporting mitochondrial morphological changes by SPG13-associated HSPD1 mutants.</pubmed_title><pmcid>PMC4716458</pmcid><pubmed_authors>Eguchi T</pubmed_authors><pubmed_authors>Tanoue A</pubmed_authors><pubmed_authors>Yamauchi J</pubmed_authors><pubmed_authors>Megumi FT</pubmed_authors><pubmed_authors>Hasegawa N</pubmed_authors><pubmed_authors>Tamura H</pubmed_authors><pubmed_authors>Miyamoto Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Data supporting mitochondrial morphological changes by SPG13-associated HSPD1 mutants.</name><description>The data is related to the research article entitled "Hypomyelinating leukodystrophy-associated missense mutation in HSPD1 blunts mitochondrial dynamics" [1]. In addition to hypomyelinating leukodystrophy (HLD) 4 (OMIM no. 612233), it is known that spastic paraplegia (SPG) 13 (OMIM no. 605280) is caused by HSPD1's amino acid mutation. Two amino acid mutations Val-98-to-Ile (V98I) and Gln-461-to-Glu (Q461E) are associated with SPG13 [2]. In order to investigate the effects of HSPD1's V98I or Q461E mutant on mitochondrial morphological changes, we transfected each of the respective mutant-encoding genes into Cos-7 cells. Either of V98I or Q461E mutant exhibited increased number of mitochondria and short length mitochondrial morphologies. Using MitoTracker dye-incorporating assay, decreased mitochondrial membrane potential was also observed in both cases. The data described here supports that SPG13-associated HSPD1 mutant participates in causing aberrant mitochondrial morphological changes with decreased activities.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Mar</publication><modification>2020-11-08T09:59:46Z</modification><creation>2019-03-27T02:07:03Z</creation></dates><accession>S-EPMC4716458</accession><cross_references><pubmed>26900593</pubmed><doi>10.1016/j.dib.2015.12.038</doi></cross_references></HashMap>